Trials / Completed
CompletedNCT00732602
The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- University Hospital, Gentofte, Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Glucose-dependent Insulinotropic Polypeptide (GIP) or Glucagon Like Peptide 2 (GLP-2) has an affect on the secretion of Glucagon from the pancreas in patients with type 1 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | GIP-infusion | |
| OTHER | Sodium-chloride | |
| OTHER | GLP-2 infusion |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-08-01
- First posted
- 2008-08-12
- Last updated
- 2009-02-13
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00732602. Inclusion in this directory is not an endorsement.